Newsroom

Newsroom

NeoGenomics announces speaker program, ‘Minimal Residual Disease in Colorectal Cancer’

Blog
Read More

NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022

Press Release
Read More

Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma

Literature
Read More

IVDR at NeoGenomics

Blog
Read More

NeoGenomics Lab Operations | Hurricane Ian Update

Press Release
Read More

NeoGenomics Hurricane Ian Emergency Response

Blog
Read More

NeoGenomics Hurricane Ian Emergency Response

Press Release
Read More

Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients